What is Amuvatinib used for?

Amuvatinib is being studied for the treatment of small cell lung carcinoma and other neoplasms.

Is Amuvatinib approved for use?

No, Amuvatinib is currently in the research phase (Phase 2) and is not yet an approved drug.

What type of drug is Amuvatinib?

Amuvatinib is classified as a small molecule drug.

What are the known uses for Amuvatinib?

Research is currently focusing on its use for small cell lung carcinoma and general neoplasms.

Is Amuvatinib safe for cancer patients?

Because Amuvatinib is still in clinical trials, its full safety profile and side effects are still being determined.

What is the chemical formula for Amuvatinib?

The chemical formula for Amuvatinib is C23H21N5O3S.

amuvatinib | CAS 850879-09-3 | FOFDIMHVKGYHRU

Loading compound...

Small molecule cancer research drug

Amuvatinib is a small molecule drug currently being studied for its potential to treat certain types of cancer, including small cell lung carcinoma and other neoplasms.

How it worksAmuvatinib is a small molecule being investigated for its ability to target specific biological pathways related to cancer growth.

Used for

Small cell lung carcinomaNeoplasms (tumors/cancer)

Conditions

Small cell lung carcinomaNeoplasms

Class

Small moleculeSmall molecule cancer research drugOncology

How to take

Amuvatinib is currently in clinical development (Max Phase 2) and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

·Is Amuvatinib part of any clinical trials I might qualify for?
·What are the expected side effects of Amuvatinib in current studies?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)